Literature DB >> 24265284

Increase in tendon protein synthesis in response to insulin-like growth factor-I is preserved in elderly men.

Rie Harboe Nielsen1, Lars Holm, Nikolaj Mølkjær Malmgaard-Clausen, Søren Reitelseder, Katja Maria Heinemeier, Michael Kjaer.   

Abstract

Insulin-like growth factor-I (IGF-I) is known to be an anabolic factor in tendon, and the systemic levels are reduced with aging. However, it is uncertain how tendon fibroblasts are involved in tendon aging and how aging cells respond to IGF-I. The purpose of this study was to investigate the in vivo IGF-I stimulation of tendon protein synthesis in elderly compared with young men. We injected IGF-I in the patellar tendons of young (n = 11, 20-30 yr of age) and old (n = 11, 66-75 yr of age) men, and the acute fractional synthesis rate (FSR) of tendon protein was measured with the stable isotope technique and compared with the contralateral side (injected with saline as control). We found that tendons injected with IGF-I had significantly higher protein FSR compared with controls (old group: 0.018 ± 0.015 vs. 0.008 ± 0.008, young group: 0.016 ± 0.009 vs. 0.009 ± 0.006%/h, mean ± SE, P < 0.01). This increase in protein synthesis was seen in both young and old men, with no differences between age groups. The old group had markedly lower serum IGF-I levels compared with young (165 ± 17 vs. 281 ± 27 ng/ml, P < 0.01). In conclusion, local IGF-I stimulated tendon protein synthesis in both young and old men, despite lower systemic IGF-I levels in the old group. This could indicate that the changed phenotype in aging tendon is not caused by decreased fibroblast function.

Entities:  

Keywords:  growth factors; growth hormone; protein turnover; tenocytes

Mesh:

Substances:

Year:  2013        PMID: 24265284     DOI: 10.1152/japplphysiol.01084.2013

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

Review 1.  The impact of loading, unloading, ageing and injury on the human tendon.

Authors:  S Peter Magnusson; Michael Kjaer
Journal:  J Physiol       Date:  2018-07-19       Impact factor: 5.182

2.  Insulin-like growth factor 1 signaling in tenocytes is required for adult tendon growth.

Authors:  Nathaniel P Disser; Kristoffer B Sugg; Jeffrey R Talarek; Dylan C Sarver; Brennan J Rourke; Christopher L Mendias
Journal:  FASEB J       Date:  2019-09-16       Impact factor: 5.191

3.  Insulin immobilized PCL-cellulose acetate micro-nanostructured fibrous scaffolds for tendon tissue engineering.

Authors:  Daisy M Ramos; Sama Abdulmalik; Michael R Arul; Swetha Rudraiah; Cato T Laurencin; Augustus D Mazzocca; Sangamesh G Kumbar
Journal:  Polym Adv Technol       Date:  2019-02-04       Impact factor: 3.665

4.  Gender associated muscle-tendon adaptations to resistance training.

Authors:  Gerard McMahon; Christopher I Morse; Keith Winwood; Adrian Burden; Gladys L Onambélé
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

5.  Existence of life-time stable proteins in mature rats-Dating of proteins' age by repeated short-term exposure to labeled amino acids throughout age.

Authors:  Cecilie Leidesdorff Bechshøft; Peter Schjerling; Andreas Bornø; Lars Holm
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

6.  Protein synthesis rates of muscle, tendon, ligament, cartilage, and bone tissue in vivo in humans.

Authors:  Joey S J Smeets; Astrid M H Horstman; Georges F Vles; Pieter J Emans; Joy P B Goessens; Annemie P Gijsen; Janneau M X van Kranenburg; Luc J C van Loon
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

7.  Muscle and tendon adaptations to moderate load eccentric vs. concentric resistance exercise in young and older males.

Authors:  Jonathan Iain Quinlan; Martino Vladimiro Franchi; Nima Gharahdaghi; Francesca Badiali; Susan Francis; Andrew Hale; Bethan Eileen Phillips; Nathaniel Szewczyk; Paul Leonard Greenhaff; Kenneth Smith; Constantinos Maganaris; Phillip James Atherton; Marco Vincenzo Narici
Journal:  Geroscience       Date:  2021-07-01       Impact factor: 7.713

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.